Skip to main
USPH

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy is a well-capitalized company with a strong balance sheet and cash flow, allowing them to continue their acquisition and de novo (new clinic) expansion strategy. Their recent acquisition and partnership agreements with hospitals and medical facilities show potential for increased revenue and profitability in the long term. However, there are potential risks such as reimbursement pressure from Medicare and economic fluctuations that could negatively impact profitability and growth. Overall, US Physical Therapy's strong financials and growth potential make it an attractive investment opportunity.

Bears say

US Physical Therapy is facing challenges in the short term, including a decrease in patient visits and revenue due to weather and the loss of partnership opportunities. Additionally, their IIP business may see a slowdown in growth due to the impact of weather and the recent acquisition. These factors, along with the high costs of salaries and operating expenses, may lead to decreased profitability in the near future. Furthermore, their reliance on managed care programs and workers' compensation insurance may make their revenue stream unstable in times of economic downturn.

USPH has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 4 analysts, USPH has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $97.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $97.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.